Global Pediatric Vaccine Market Trends, Strategies, And Opportunities In The Pediatric Vaccine Market 2021-2030

Pediatric Vaccine Market Report 2021: COVID 19 Growth And Change To 2030

Pediatric Vaccine Global Market Report 2021: COVID 19 Growth And Change To 2030

The Business Research Company’s Pediatric Vaccine Global Market Report 2021: COVID 19 Growth And Change To 2030

LONDON, GREATER LONDON , UK, June 10, 2021 / — According to the new market research report ‘Pediatric Vaccine Global Market Report 2021: COVID 19 Growth And Change To 2030’ published by The Business Research Company, the global pediatric vaccine market is expected to grow from $28.97 billion in 2020 to $32.44 billion in 2021 at a compound annual growth rate (CAGR) of 12%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $49.9 billion in 2025 at a CAGR of 11.4%. The rising prevalence of chronic diseases such as tuberculosis, diphtheria, and pneumonia in the age group of 15 years and below will contribute to the growth of the pediatric vaccines market.

Request For A Sample For The Global Pediatric Vaccine Market Report:

The pediatric vaccines market consists of sales of pediatric vaccines and its related services used to provide immunity to infants and children for specific diseases. The pediatric vaccine is a preparation of killed microorganisms, living attenuated organisms, or living fully virulent organisms that are administered to stimulate the production of antibodies and provide immunity against one or several diseases among children. Pediatric vaccines are used in childhood immunization schedules to enhance a child’s immunity or prevent diseases such as diphtheria, tetanus, pertussis, influenza, Hepatitis B, polio, and many other infectious and non-infectious diseases.

Trends In The Global Pediatric Vaccine Market
The demand for novel vaccines is steadily growing to deliver improved immunization against challenging infectious diseases (e.g. tuberculosis, HIV/ AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant recombinant antigen formulations. To meet the increasing demand for novel vaccines, there is a continuous quest for pediatric vaccine manufacturers and developers for innovation of vaccine design and manufacturing technologies. For instance, in January 2020, Hilleman laboratories, global research, and development organization, has announced their plans to develop a novel vaccine against Group B Streptococcus, a major cause for neonatal infections in women, in the area of maternal and child health.

Global Pediatric Vaccine Market Segments:
The global pediatric vaccine market is further segmented based on type, technology, application and geography.
By Vaccine Type: Monovalent, Multivalent
By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies
By Application: Infectious Disease, Allergy, Cancer
By Geography: The global pediatric vaccine market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Pediatric Vaccine Market At:

Pediatric Vaccine Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides pediatric vaccine global market overviews, analyzes and forecasts market size and growth for the global pediatric vaccine market, pediatric vaccine market share, pediatric vaccine global market players, pediatric vaccine market segments and geographies, pediatric vaccine global market’s leading competitors’ revenues, profiles and market shares. The pediatric vaccine global market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read Pediatric Vaccine Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Pediatric Vaccine Market Organizations Covered: GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Indian Immunologicals Limited, AstraZeneca plc, CSL Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Pediatric Vaccine Global Market Report 2021:

Vaccines Global Market Report 2021: COVID-19 Impact And Recovery To 2030

Antivirals Global Market Report 2021: COVID 19 Implications And Growth To 2030

Oncology Drugs Market – By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid Cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies – Global Forecast To 2030

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Leave a Reply

Your email address will not be published.